Conclusion Glutathione IV therapy offers powerful benefits, from detoxifying the body to enhancing skin brightness, boosting immunity, and improving energy levels
GHK-Cu adds another layer of concern because FDA has specifically discussed immunogenicity risk for injectable GHK-Cu related to potential aggregation and peptide-related impurities
Electronic Code of Federal Regulations: 21 CFR 216.23 Current formal 503A Bulks List and the regulatory warning that list inclusion is not FDA approval or endorsement
Additionally, when the body is exposed to high oxidative stress, malnutrition, or an increase in toxic load from environmental contaminants, the need for glutathione increases
The clinical case presented allowed us to reflect on the thin red line between the symptoms that may indicate a disease recurrence and those related to opioid tapering, focusing our attention on the need for adequate tools to monitor patients during the deprescribing process
10.1038/288715a0 Nature 19 PickartL.Vasquez-SolteroJ